ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
Ruth Cheng, appointed new president and CEO of ATCC, succeeds Raymond Cypess, who will remain on the Board of Directors as chairman.
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
NCI awarded ATCC a 5-year contract with a ceiling value of $4.06 million to provide lab services that support HIV and HTLV-1 research and vaccine development.
